Healthcare technology company Cue Health (Nasdaq: HLTH) announced that it has been awarded a contract worth approximately $28 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). The contract is aimed at developing a molecular multiplex test for Flu A/B, RSV, and COVID-19 […]
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially against biothreats. SIGA Technologies is a US-based commercial-stage pharmaceutical company, whose lead product is TPOXX. Also called tecovirimat and ST-246, TPOXX is an orally administered and intravenous (IV) formulation antiviral […]
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for Covid-19 to the US government. The US biotech company said that the award for the mRNA vaccine candidate includes incentive payments for the timely supply of the product. As per […]
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]
Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this year, which it aims to bring it to the market in early 2021 through emergency use authorization. The company, in this connection, said that its subsidiary Janssen Pharmaceutical has significantly […]
Actemra coronavirus clinical trial : Genentech has been given approval by the US Food & Drug Administration (FDA) to undertake the phase 3 COVACTA trial to assess the safety and efficacy of intravenous Actemra (tocilizumab) along with standard of care in hospitalized adults having severe COVID-19 pneumonia. The Roche subsidiary will carry out the randomized, […]
Siga Technologies has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of its orally administered antiviral drug, TPOXX (tecovirimat), for the treatment of smallpox. This approval marks a critical development in public health preparedness and bioterrorism defense. Developed in collaboration with the U.S. Department of Health and Human Services’ Biomedical […]